<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E3D2D81D-2671-410B-9D1C-BBBBDA8CF466"><gtr:id>E3D2D81D-2671-410B-9D1C-BBBBDA8CF466</gtr:id><gtr:name>Johnson &amp; Johnson Ltd</gtr:name><gtr:address><gtr:line1>Foundation Park</gtr:line1><gtr:line2>Roxborough Way</gtr:line2><gtr:line4>Maidenhead</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>SLG 3UG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C1E0E310-885F-4DC7-B908-31AACD12FAFA"><gtr:id>C1E0E310-885F-4DC7-B908-31AACD12FAFA</gtr:id><gtr:name>Boehringer Ingelheim</gtr:name><gtr:address><gtr:line1>Corporate Division Communications</gtr:line1><gtr:line2>Binger Strasse 173</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:department>College of Life Sciences</gtr:department><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E3D2D81D-2671-410B-9D1C-BBBBDA8CF466"><gtr:id>E3D2D81D-2671-410B-9D1C-BBBBDA8CF466</gtr:id><gtr:name>Johnson &amp; Johnson Ltd</gtr:name><gtr:address><gtr:line1>Foundation Park</gtr:line1><gtr:line2>Roxborough Way</gtr:line2><gtr:line4>Maidenhead</gtr:line4><gtr:line5>Berkshire</gtr:line5><gtr:postCode>SLG 3UG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1E0E310-885F-4DC7-B908-31AACD12FAFA"><gtr:id>C1E0E310-885F-4DC7-B908-31AACD12FAFA</gtr:id><gtr:name>Boehringer Ingelheim</gtr:name><gtr:address><gtr:line1>Corporate Division Communications</gtr:line1><gtr:line2>Binger Strasse 173</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DB5BF9B1-28AD-495C-A699-B529E617BDBB"><gtr:id>DB5BF9B1-28AD-495C-A699-B529E617BDBB</gtr:id><gtr:firstName>Doreen</gtr:firstName><gtr:surname>Cantrell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1100713"><gtr:id>EDEECA77-624F-4BD1-8156-180B7AD0D04A</gtr:id><gtr:title>Capital award</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1100713</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2012-02-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1412000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boehringer Ingelheim</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Division of Signal Transduction Therapy Cell signalling consortium</gtr:description><gtr:id>EA909246-8630-4019-A65F-3A2172B764A5</gtr:id><gtr:impact>Ongoing and too early for tangible outputs</gtr:impact><gtr:outcomeId>sY52EKSLAaH-3</gtr:outcomeId><gtr:partnerContribution>Advice on the pathways of most interest to industry and where greatest benefit would be obtained</gtr:partnerContribution><gtr:piContribution>We are developing mass spectrometry based methods that will improve the undertsanding of the effects of modulators on cell signalling which as a result of the basic research will support the drug development process</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Division of Signal Transduction Therapy Cell signalling consortium</gtr:description><gtr:id>E23287B5-D375-44C7-9E7F-7B0E6A3B3E06</gtr:id><gtr:impact>Ongoing and too early for tangible outputs</gtr:impact><gtr:outcomeId>sY52EKSLAaH-1</gtr:outcomeId><gtr:partnerContribution>Advice on the pathways of most interest to industry and where greatest benefit would be obtained</gtr:partnerContribution><gtr:piContribution>We are developing mass spectrometry based methods that will improve the undertsanding of the effects of modulators on cell signalling which as a result of the basic research will support the drug development process</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Merck</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Division of Signal Transduction Therapy Cell signalling consortium</gtr:description><gtr:id>778A62A8-6DBB-4BA2-B918-5DBA03EFDE2F</gtr:id><gtr:impact>Ongoing and too early for tangible outputs</gtr:impact><gtr:outcomeId>sY52EKSLAaH-5</gtr:outcomeId><gtr:partnerContribution>Advice on the pathways of most interest to industry and where greatest benefit would be obtained</gtr:partnerContribution><gtr:piContribution>We are developing mass spectrometry based methods that will improve the undertsanding of the effects of modulators on cell signalling which as a result of the basic research will support the drug development process</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Division of Signal Transduction Therapy Cell signalling consortium</gtr:description><gtr:id>0EAF70F3-0FA2-4A9F-A0D3-BE65FA3FF7D1</gtr:id><gtr:impact>Ongoing and too early for tangible outputs</gtr:impact><gtr:outcomeId>sY52EKSLAaH-2</gtr:outcomeId><gtr:partnerContribution>Advice on the pathways of most interest to industry and where greatest benefit would be obtained</gtr:partnerContribution><gtr:piContribution>We are developing mass spectrometry based methods that will improve the undertsanding of the effects of modulators on cell signalling which as a result of the basic research will support the drug development process</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Division of Signal Transduction Therapy Cell signalling consortium</gtr:description><gtr:id>EC611CE7-3A34-4B95-89D3-F868C83DC1B3</gtr:id><gtr:impact>Ongoing and too early for tangible outputs</gtr:impact><gtr:outcomeId>sY52EKSLAaH-6</gtr:outcomeId><gtr:partnerContribution>Advice on the pathways of most interest to industry and where greatest benefit would be obtained</gtr:partnerContribution><gtr:piContribution>We are developing mass spectrometry based methods that will improve the undertsanding of the effects of modulators on cell signalling which as a result of the basic research will support the drug development process</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johnson &amp; Johnson</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Janssen Pharmaceuticals</gtr:department><gtr:description>Division of Signal Transduction Therapy Cell signalling consortium</gtr:description><gtr:id>7C45228C-30CB-4D35-959B-68607168DED6</gtr:id><gtr:impact>Ongoing and too early for tangible outputs</gtr:impact><gtr:outcomeId>sY52EKSLAaH-4</gtr:outcomeId><gtr:partnerContribution>Advice on the pathways of most interest to industry and where greatest benefit would be obtained</gtr:partnerContribution><gtr:piContribution>We are developing mass spectrometry based methods that will improve the undertsanding of the effects of modulators on cell signalling which as a result of the basic research will support the drug development process</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>87262</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SRM analysis of the phosphorylation status of protein kinases</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:fundingRef>A853/0142</gtr:fundingRef><gtr:id>B3C4966B-5E70-4944-81C0-6DF25EA524AE</gtr:id><gtr:outcomeId>jwMDSLMBGkq</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>87262</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SRM analysis of the phosphorylation status of protein kinases</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>MRC-Technology</gtr:fundingOrg><gtr:fundingRef>A853/0142</gtr:fundingRef><gtr:id>39297E10-F043-484B-9E58-FE8C54F7241F</gtr:id><gtr:outcomeId>56dd4dcd669b93.44100940</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>407142</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research projects</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Michael J Fox Foundation</gtr:fundingOrg><gtr:id>ED6A6859-8E61-4C9A-BA50-4F5E293AE4BA</gtr:id><gtr:outcomeId>du2zLRCtQQS</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>407142</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research projects</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Michael J Fox Foundation</gtr:fundingOrg><gtr:id>D6F96794-D934-465F-AC7D-E38147D35FF4</gtr:id><gtr:outcomeId>56dd4d75a4db96.67133008</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>885CCF64-846F-40A9-ABF8-C52E7C835632</gtr:id><gtr:title>O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14183c5032f0f6dfbece3576956c8e8a"><gtr:id>14183c5032f0f6dfbece3576956c8e8a</gtr:id><gtr:otherNames>Pathak S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_14056_26_22307082</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58DCCC07-4E02-48E4-A22A-23AFC5B3D88B</gtr:id><gtr:title>IFNs Modify the Proteome of Legionella-Containing Vacuoles and Restrict Infection Via IRG1-Derived Itaconic Acid.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a9e5de444a33ae7e644943157753ac2"><gtr:id>6a9e5de444a33ae7e644943157753ac2</gtr:id><gtr:otherNames>Naujoks J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56cc73dcd4f153.49230689</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F95DB6E-0F8B-4C10-8FA5-94E2FFCD33A2</gtr:id><gtr:title>Protein kinase D2 is a digital amplifier of T cell receptor-stimulated diacylglycerol signaling in na&amp;iuml;ve CD8? T cells.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b5dfc97807d7e421f2c059be80cb506"><gtr:id>6b5dfc97807d7e421f2c059be80cb506</gtr:id><gtr:otherNames>Navarro MN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>56cc73df0e03f3.25431204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>219A46CE-1EED-4E49-AB7D-B73E010348DF</gtr:id><gtr:title>The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b83b043152f9dd1fc9c808e165ee424"><gtr:id>1b83b043152f9dd1fc9c808e165ee424</gtr:id><gtr:otherNames>Strickson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_14056_26_23441730</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76A43E9C-8221-4CAB-B9DB-1F4E7275D66C</gtr:id><gtr:title>Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3af18b6a48e1cb8adf61b897c0097848"><gtr:id>3af18b6a48e1cb8adf61b897c0097848</gtr:id><gtr:otherNames>Clark K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14056_26_23033494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93F993FD-F918-4514-BCFC-B015729CBBC3</gtr:id><gtr:title>Protein degradation and dynamic tRNA thiolation fine-tune translation at elevated temperatures.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e7717e6f7e3667e94a7ec69406c96b4"><gtr:id>2e7717e6f7e3667e94a7ec69406c96b4</gtr:id><gtr:otherNames>Tyagi K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>56cc78fe490377.58902105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1B383F0-CF70-4BB5-BD60-02EB13A76C8D</gtr:id><gtr:title>Phosphorylation of Parkin at Serine65 is essential for activation: elaboration of a Miro1 substrate-based assay of Parkin E3 ligase activity.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac12dfa46c116740844c796a1d6eae70"><gtr:id>ac12dfa46c116740844c796a1d6eae70</gtr:id><gtr:otherNames>Kazlauskaite A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>56cc78feb2f6c3.13343973</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC6343D7-0811-43C0-B703-7592259296B5</gtr:id><gtr:title>The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/503273474c456315c93d79baa7a3978b"><gtr:id>503273474c456315c93d79baa7a3978b</gtr:id><gtr:otherNames>Dzamko N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_14056_ne_0039132</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3CCA5E3-0B2C-4EFC-BED6-80CFA0F2D18D</gtr:id><gtr:title>tRNA tKUUU, tQUUG, and tEUUC wobble position modifications fine-tune protein translation by promoting ribosome A-site binding.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52bfeca0a8ca47f068eeddccb0d84264"><gtr:id>52bfeca0a8ca47f068eeddccb0d84264</gtr:id><gtr:otherNames>Rezgui VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56cc78ff2d77b9.13369650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>313EB9A9-1F58-4C6C-95CD-C4B9C89928C7</gtr:id><gtr:title>Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42c5535937f784a4c0ad3bc626073c7e"><gtr:id>42c5535937f784a4c0ad3bc626073c7e</gtr:id><gtr:otherNames>Emmerich CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56cc78fef29385.92344247</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D092403F-82AB-43FE-B2BA-E13703A24BB9</gtr:id><gtr:title>High-resolution quantitative proteome analysis reveals substantial differences between phagosomes of RAW 264.7 and bone marrow derived macrophages.</gtr:title><gtr:parentPublicationTitle>Proteomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc3f35c735fb08592cad4946e87f06d4"><gtr:id>cc3f35c735fb08592cad4946e87f06d4</gtr:id><gtr:otherNames>Guo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1615-9853</gtr:issn><gtr:outcomeId>56cc73dde91950.90124727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8072720-00B8-4AC3-A37C-1D1ECAB18174</gtr:id><gtr:title>Ubiquitylation-dependent localization of PLK1 in mitosis.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>pm_14056_26_23455478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30BEB34B-DF50-432E-9B02-6E0C6E8478A4</gtr:id><gtr:title>Screening of DUB activity and specificity by MALDI-TOF mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35f54c2ab1237f6ddaf41008f895f52a"><gtr:id>35f54c2ab1237f6ddaf41008f895f52a</gtr:id><gtr:otherNames>Ritorto MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56cc73df39f8b6.56325970</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDAA573D-0EED-468D-BBC8-E589235B6168</gtr:id><gtr:title>Proteomic identification of novel secreted antibacterial toxins of the Serratia marcescens type VI secretion system.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ac0794451bf98fb2693410c444866f5"><gtr:id>1ac0794451bf98fb2693410c444866f5</gtr:id><gtr:otherNames>Fritsch MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn><gtr:outcomeId>56cc78fe14a973.33089999</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B30F45A-2A10-496D-BA87-C0B909DE630B</gtr:id><gtr:title>Ubiquitin C-terminal hydrolases cleave isopeptide- and peptide-linked ubiquitin from structured proteins but do not edit ubiquitin homopolymers.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b32fc6ad52ed003bb0738525ef22686b"><gtr:id>b32fc6ad52ed003bb0738525ef22686b</gtr:id><gtr:otherNames>Bett JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>56cc73de237190.84501564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E498613B-1319-4CAD-87B8-43305975EC74</gtr:id><gtr:title>Protein phosphatase 4 is phosphorylated and inactivated by Cdk in response to spindle toxins and interacts with ?-tubulin.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da1df71f13ee89fd3fc5bb0ab619ebe0"><gtr:id>da1df71f13ee89fd3fc5bb0ab619ebe0</gtr:id><gtr:otherNames>Voss M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_14056_26_23966160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F62F850-2F1C-48C3-A1DB-9BC75F4DF488</gtr:id><gtr:title>A combination of SILAC and nucleotide acyl phosphate labelling reveals unexpected targets of the Rsk inhibitor BI-D1870</gtr:title><gtr:parentPublicationTitle>Bioscience Reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71f1729c1f506142e73ebf0a70c5487d"><gtr:id>71f1729c1f506142e73ebf0a70c5487d</gtr:id><gtr:otherNames>Edgar A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0144-8463</gtr:issn><gtr:outcomeId>56cc78fdd18807.35040844</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A6B6783-FC37-4D14-85CC-DCCF5774F73E</gtr:id><gtr:title>Hydrophilic strong anion exchange (hSAX) chromatography for highly orthogonal peptide separation of complex proteomes.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35f54c2ab1237f6ddaf41008f895f52a"><gtr:id>35f54c2ab1237f6ddaf41008f895f52a</gtr:id><gtr:otherNames>Ritorto MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>56cc73e0247e59.33957767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46A0FCEF-30C6-45C6-9E70-BC26DF4C686F</gtr:id><gtr:title>VAPB/ALS8 interacts with FFAT-like proteins including the p97 cofactor FAF1 and the ASNA1 ATPase.</gtr:title><gtr:parentPublicationTitle>BMC biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ba4fef821b822423b12155cb8670f38"><gtr:id>6ba4fef821b822423b12155cb8670f38</gtr:id><gtr:otherNames>Baron Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1741-7007</gtr:issn><gtr:outcomeId>56cc78fe7fc8c4.17354549</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E3FB85C-FF97-4113-BF96-30E83443BB22</gtr:id><gtr:title>A crucial role for ?2 integrins in podosome formation, dynamics and Toll-like-receptor-signaled disassembly in dendritic cells.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0c942b776475ae17f78f4b8324b75f2"><gtr:id>c0c942b776475ae17f78f4b8324b75f2</gtr:id><gtr:otherNames>Gawden-Bone C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>56cc73df6d5626.57345912</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22D02F42-1472-447D-BFFE-458BD435B20E</gtr:id><gtr:title>Quantitative proteomics reveals that only a subset of the endoplasmic reticulum contributes to the phagosome.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a283f9cc8144532acf786fe0afcc260"><gtr:id>3a283f9cc8144532acf786fe0afcc260</gtr:id><gtr:otherNames>Campbell-Valois FX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn><gtr:outcomeId>pm_14056_26_22427703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7587A7B1-D7AC-4EC7-AD46-C7A53CAF233E</gtr:id><gtr:title>Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c1b33bb36e9bebb791a54b932f34dba"><gtr:id>4c1b33bb36e9bebb791a54b932f34dba</gtr:id><gtr:otherNames>Lai YC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>56cc73dd4f0e04.86257381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0276DA8-FBB2-4A84-B3BB-210FE2EE6884</gtr:id><gtr:title>Hydrophilic strong anion exchange chromatography for proteomics: what's the future outlook?</gtr:title><gtr:parentPublicationTitle>Bioanalysis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35f54c2ab1237f6ddaf41008f895f52a"><gtr:id>35f54c2ab1237f6ddaf41008f895f52a</gtr:id><gtr:otherNames>Ritorto MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1757-6180</gtr:issn><gtr:outcomeId>56cc73dfef66f8.04757553</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0ADCD633-EE33-444A-8881-800B2227E17E</gtr:id><gtr:title>Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac12dfa46c116740844c796a1d6eae70"><gtr:id>ac12dfa46c116740844c796a1d6eae70</gtr:id><gtr:otherNames>Kazlauskaite A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>56cc73dd81c951.21735685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4736C43-7824-4247-84E9-D4B6E25F451A</gtr:id><gtr:title>PGE(2) induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIK-CRTC3 pathway.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96b40aa5de27031cfad4d0acc4814787"><gtr:id>96b40aa5de27031cfad4d0acc4814787</gtr:id><gtr:otherNames>MacKenzie KF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14056_26_23241891</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6723E024-2553-4AA1-B609-1A53CAAF1E7E</gtr:id><gtr:title>The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b32fc6ad52ed003bb0738525ef22686b"><gtr:id>b32fc6ad52ed003bb0738525ef22686b</gtr:id><gtr:otherNames>Bett JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_14056_26_23398456</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>100DD58D-EE1D-4F05-AC57-31E681C99741</gtr:id><gtr:title>Identification of the amino acids 300-600 of IRS-2 as 14-3-3 binding region with the importance of IGF-1/insulin-regulated phosphorylation of Ser-573.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e49e0bf9925917e1614eb7ad3c09951"><gtr:id>3e49e0bf9925917e1614eb7ad3c09951</gtr:id><gtr:otherNames>Neukamm SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14056_26_22912850</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C0276CB-4868-4368-8E1D-E7F2A300C7FD</gtr:id><gtr:title>ZNRF2 is released from membranes by growth factors and, together with ZNRF1, regulates the Na+/K+ATPase.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d21ad7f4b34468a363874abc6405548"><gtr:id>3d21ad7f4b34468a363874abc6405548</gtr:id><gtr:otherNames>Hoxhaj G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>pm_14056_26_22797923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D297D0FD-7A04-472B-950E-FF601D8C05D7</gtr:id><gtr:title>Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cf7e3a2fde2207721e68e2f70ec9402"><gtr:id>8cf7e3a2fde2207721e68e2f70ec9402</gtr:id><gtr:otherNames>Steger M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>56cc73dd1eb0c7.65819809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8153BF9-BE97-43ED-9990-8E893090C300</gtr:id><gtr:title>A holin and an endopeptidase are essential for chitinolytic protein secretion in Serratia marcescens.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed799ad0495668264e2fa6865ffa5f0b"><gtr:id>ed799ad0495668264e2fa6865ffa5f0b</gtr:id><gtr:otherNames>Hamilton JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>56cc78fd6a3df3.21516777</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F5ABFE7-23A1-4FDD-A66A-71BCB6246DDC</gtr:id><gtr:title>Quantitative proteome analysis of temporally resolved phagosomes following uptake via key phagocytic receptors.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2c08b63d42d04c9eaf0773ff078a40b"><gtr:id>a2c08b63d42d04c9eaf0773ff078a40b</gtr:id><gtr:otherNames>Dill BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn><gtr:outcomeId>56cc73ddb34bc8.34213851</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6FBE856-54B3-44E8-871E-ACE37123C318</gtr:id><gtr:title>Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac12dfa46c116740844c796a1d6eae70"><gtr:id>ac12dfa46c116740844c796a1d6eae70</gtr:id><gtr:otherNames>Kazlauskaite A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>56cc73dfba2810.71861154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B7D25A1-0719-4641-8C70-68697B76C0F4</gtr:id><gtr:title>Arabidopsis thaliana histone deacetylase 14 (HDA14) is an a-tubulin deacetylase that associates with PP2A and enriches in the microtubule fraction with the putative histone acetyltransferase ELP3.</gtr:title><gtr:parentPublicationTitle>The Plant journal : for cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/445f4a7cae2337f25de1d2bfe8aca68b"><gtr:id>445f4a7cae2337f25de1d2bfe8aca68b</gtr:id><gtr:otherNames>Tran HT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-7412</gtr:issn><gtr:outcomeId>pm_14056_26_22404109</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>521CC266-1198-4766-BA85-0D07030F4884</gtr:id><gtr:title>Phosphorylation of FOXO3a on Ser-7 by p38 promotes its nuclear localization in response to doxorubicin.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0cd06eff3f05d46bc21d2e8e16f7aab"><gtr:id>b0cd06eff3f05d46bc21d2e8e16f7aab</gtr:id><gtr:otherNames>Ho KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>c4vGSLMMd3r</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DECEC69-476F-4753-8A0B-BC9F6E3C2027</gtr:id><gtr:title>Reproducible automated phosphopeptide enrichment using magnetic TiO2 and Ti-IMAC.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71880884a5d2681d806ca27e34b02a3b"><gtr:id>71880884a5d2681d806ca27e34b02a3b</gtr:id><gtr:otherNames>Tape CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>56cc78fd9d8993.60022226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F8D7DA5-0430-4EE4-B4DB-15ED834B2D5E</gtr:id><gtr:title>PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65b17fed4915e03ecad9b5f9436124ae"><gtr:id>65b17fed4915e03ecad9b5f9436124ae</gtr:id><gtr:otherNames>Kondapalli C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>pm_14056_26_22724072</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BFF7DAB-4860-400D-B760-4A1E32C96532</gtr:id><gtr:title>Isolation of human mitotic protein phosphatase complexes: identification of a complex between protein phosphatase 1 and the RNA helicase Ddx21.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e91f63f74f036645dd0b779fad56e81f"><gtr:id>e91f63f74f036645dd0b779fad56e81f</gtr:id><gtr:otherNames>De Wever V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14056_26_22761809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBCC21DD-662C-4568-A9B8-859193C3E0C0</gtr:id><gtr:title>Dissociable effects of surprise and model update in parietal and anterior cingulate cortex.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b1b9f453d410aae107c5454b62ad74f"><gtr:id>5b1b9f453d410aae107c5454b62ad74f</gtr:id><gtr:otherNames>O'Reilly JX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14056_26_23986499</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1100713</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>